{
    "title": "WHO recommends Merck's COVID pill for high-risk patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10571281/WHO-recommends-Mercks-COVID-pill-high-risk-patients.html",
    "date": "2022-03-02",
    "keywords": [
        "panel",
        "pill",
        "use",
        "covid19",
        "incs",
        "molnupiravir",
        "risk",
        "hospitalisation",
        "recommendation",
        "group",
        "antibody",
        "march",
        "world",
        "health",
        "organization",
        "wednesday",
        "merck",
        "amp",
        "co",
        "highrisk",
        "disease",
        "authorization",
        "demand",
        "hit",
        "efficacy",
        "safety",
        "pfizer",
        "antiviral",
        "guideline",
        "development",
        "gdg",
        "care",
        "developing",
        "fetus",
        "animal",
        "httpswwwbmjcomcontent370bmjm3379",
        "journal",
        "illness",
        "trial",
        "guidance",
        "regeneron",
        "drug",
        "omicron",
        "data",
        "variant",
        "lillys",
        "baricitinib",
        "combination",
        "glaxosmithkline",
        "vir",
        "biotechnologys",
        "therapy",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}